What are the benefits and impacts of the project?
The Newlife project aims to improve pregnancy care and newborn health by providing innovative solutions that are user-friendly, cost-effective, and scalable. The project hopes to contribute to reducing maternal and infant mortality and morbidity rates, as well as enhancing the quality of life of mothers and babies.
The Newlife consortium held its semi-annual meeting in June 2023 in Finland, where they discussed the progress and challenges of the project. The next meeting will take place in December 2023 in Switzerland, where all 25 Newlife partners will showcase their achievements and demonstrate their technologies.
To learn more about how wearable sensors are transforming healthcare, explore our Digital Health solutions.
This project is supported by the Chips Joint Undertaking (Grant Agreement No. 101095792) and its members Finland, Germany, Ireland, the Netherlands, Sweden, Switzerland. This work includes top-up funding from the Swiss State Secretariat for Education, Research and Innovation (SERI)
